Clinical Research
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2007; 13(36): 4891-4896
Published online Sep 28, 2007. doi: 10.3748/wjg.v13.i36.4891
Table 2 Comparative analysis of lesion detection for 133 lesions in 59 patients using pre-contrast, ferucarbotran-enhanced, and Gd-DTPA-enhanced sequences
Sequencen (%)
< 1 cm1-3 cm> 3 cm
(n = 44 )(n = 68)(n = 21 )
1 Pre-contrast T1WI GRE15 (34.1)b48 (70.6)b21 (100.0)
2 Pre-contrast FSE T2WI with fat suppression24 (54.5)b61 (89.7)21 (100.0)
3 Dynamic Gd-DTPA- enhanced T1WI GRE35 (79.5)a67 (98.5)21 (100.0)
4 Dynamic ferucarbotran- enhanced T1WI GRE32 (72.7)62 (91.2)21 (100.0)
5 Delayed ferucarbotran-enhanced FSE T2WI with fat suppression41 (93.2)68 (100)21 (100.0)
6 Delayed ferucarbotran- enhanced GRE T2*WI39 (88.6)67 (98.5)21 (100.0)